IRIS
FRIEDMAN, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.635
Totale 11.635
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.635
Totale 11.635
Salva come PNG Salva come JPEG
Città #
Genova 8.509
Rapallo 1.699
Genoa 1.392
Bordighera 35
Totale 11.635
Salva come PNG Salva come JPEG
Nome #
Axillary ultrasound and Fine-Needle Aspiration Cytology in the preoperative staging of axillary node metastasis in breast cancer patients 199
LA RESEZIONE GASTRICA CON GASTROENTEROANASTOMOSI SECONDO ROUX PER LA TERAPIA CHIRURGICA DELL'ULCERA GASTRICA E DUODENALE. 180
FIVE YEARS' EXPERIENCE WITH HICKMAN CATHETERS AS TEMPORARY ACCESS FOR HAEMODIALYSIS. 150
Biliopancreatic diversion 150
Orbital swelling as a first symptom in breast carcinoma diagnosis: a case report 148
Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. 148
Right portal vein thrombosis after splenectomy for trauma 130
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 129
Atypical ductal hyperplasia diagnosed at 11-gauge vacuum-assisted breast biopsy performed on suspicious clustered microcalcifications: could patients without residual microcalcifications be managed conservatively? 128
How to limit lymphatic morbidity in breast cancer treatment 122
HERNIA REPAIR IN ELDERLY PATIENTS 119
Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes 119
BEHAVIORAL APPROACH TO PROMOTE EATING HABITS AND LIFESTYLE CHANGES FOLLOWING GASTRIC CHANGES FOR OBESITY 118
Flat Epithelial Atypia: Comparison Between 9-Gauge and 11-Gauge Devices 118
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 116
10 YEARS EXPERIENCE WITH BILIOPANCREATIC DIVERSION (BPD) 115
Tumescent anesthesia in skin- and nipple-sparing mastectomy: Results of a prospective clinical study 115
Comparison of local recurrence among early breast cancer patients treated with electron intraoperative radiotherapy vs hypofractionated photon radiotherapy an observational study 112
Biliopancreatic diversion for obesity at eighteen years 111
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions. 111
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 109
Surgical Prevention of Arm Lymphedema After Breast Cancer Treatment 109
CLINICAL USE OF PARTIAL BILIOPANCREATIC BYPASS FOR OBESITY. DETAILS OF OPERATIVE TECHNIQUE AND FOLLOW-UP MANAGEMENT. 109
The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases 107
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases 107
Intraoperative digital breast tomosynthesis using a dedicated device is more accurate than standard intraoperative mammography for identifying positive margins 104
BILIOPANCREATIC DIVERSION 102
Intravenous nutritional support in pregnancy. Experience followingbiliopancreatic diversion. 101
Ectopic breast cancer: case report and review of the literature. 101
A prospective multicentre survey on the treatment of acute pancreatitis in Italy 101
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 101
Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up 100
In vivo evaluation of immunological status after biliopancreatic bypass. 99
No Axillary Lymph Node Dissection in Breast Cancer Patients with Sentinel Lymph Node Micrometastasis 99
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 98
Pregnancies in an 18-year follow-up after biliopancreatic diversion 96
PROTEIN-MALNUTRITION AFTER BILIOPANCREATIC DIVERSION (BPD) 95
Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence 94
'Simple' form of Caroli's disease 90
liver morphology and function after biliopancreatic bypass 90
[Behavior of plasma insulin and GIP in obese patients subjected tobiliopancreatic bypass]. 89
AUTOLOGOUS BLOOD TRANSFUSION IN BILIOPANCREATIC BYPASS SURGERY. A PRELIMINARY REPORT. 88
CHANGES OF GASTRIC ACID SECRETION AFTER PARTIAL BILIOPANCREATIC BYPASS. 85
Tumor size-driven dose of intraoperative radiotherapy for breast cancer: 18 Gy versus 21 Gy 85
Biliopancreatic diversion. 84
Biliopancreatic bypass. 83
CHANGES OF BODY-COMPOSITION FOLLOWING BILIOPANCREATIC BYPASS (BPB) 82
CHANGES IN PLASMA GUT HORMONES AFTER BILIOPANCREATIC BYPASS FOR OBESITY. A PRELIMINARY REPORT. 81
The role of sentinel lymph node biopsy in patients with B5C breast cancer diagnosis 81
URINARY OXALATE EXCRETION AFTER BILIOPANCREATIC BYPASS. 80
THE EFFECT OF BILIOPANCREATIC DIVERSION ON SERUM CHOLESTEROL 80
SURGICAL REVISION OF BILIOPANCREATIC DIVERSION (BPD) 79
Liver morphology and function in 500 morbidly obese patients 79
Biliary ileus. Considerations in surgical strategy 79
BODY COMPOSTION IN MASSIVELY OBESE PATIENTS 77
Magnetic resonance imaging of breast cancer: Does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing? 77
EATING HABITS FOLLOWING BILIOPANCREATIC DIVERSION (BPD) 76
Partial and total biliopancreatic bypass in the surgical treatment of obesity. 75
In vivo evaluation of postoperative immunosuppression by means of Multitestsystem. 75
Hepatic effects of biliopancreatic bypass 75
[Urinary excretion of oxalate after bilio-pancreatic bypass for obesity]. 74
Behavior of plasma gastrin in obese subjects subjected to biliopancreatic bypass [Comportamento della gastrina plasmatica in soggetti obesi sottoposti a bypass biliopancreatico] 74
In vivo evaluation of cell mediated immunity by means of Mulitest system 74
Implant-Based Breast Reconstruction Using a Polyester Mesh (Surgimesh-PET): A Retrospective Single-Center Study 74
Surgical management of acute pancreatitis in Italy: Lessons from a prospective multicentre study 74
Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters 74
effect of biliopancreatic diversion on serum choestero.l 73
Etiological factors of protein malnutrition after biliopancreatic diversion. 72
A two-step selection of breast cancer patients candidates for exclusive IORT with electrons: a mono-institutional experience 72
LA CHIRURGIA MAGGIORE DELLA MAMMELLA IN DAY-SURGERY: RAZIONALE E NOSTRA ESPERIENZA 71
EVOLUTION OF BILIOPANCREATIC BYPASS. 71
[2 cases of death caused by hepatic insufficiency after jejuno-ileal bypass forobesity]. 70
Comportamento dell'insulina e del GIP plasmatici in soggetto obesi sottopost a bypass biliopancratico 70
The use of bioelectrical impedance analysis for monitoring body composition changes during nutritional support. 70
IN VIVO EVALUATION OF IMMUNOLOGICAL STATUS AFTER BILIOPANCREATIC BYPASS FOR OBESITY. 70
LA DIVERSIONE BILIOPANCREATICA A SEDICI ANNI 69
In situ ductal carcinoma of the breast: current status and our experience 69
Intraoperative radiotherapy (IORT) in relapsed breast cancer: a possibility for a new conservative therapy 69
[Protein absorption after bilio-pancreatic bypass for obesity]. 69
THE INCIDENCE OF PROTEIN MALNUTRITION (PM) AFTER "AD HOC STOMACH" (AHS) BPD CAN BE MINIMIZED, WHILE PRESERVING GOOD WEIGHT LOSS RESULTS, BY ELONGATING ALIMENTARY LIMB (AL) IN SELECTED PATIENTS 69
[Absorption of vitamin B 12 after biliopancreatic bypass for obesity]. 68
Pregnancy following surgical treatment of morbid obesity. Review of literature and our experience with biliopancreatic diversion [Gravidanza dopo terapia chirurgica dell'obesità. Revisione bibliografica e nostra esperienza con la diversione biliopancreatica] 68
BODY COMPOSITION AFTER "VERY LITTLE STOMACH" BILIOPANCREATIC BY¬PASS 67
[Evaluation of body composition in obese subjects]. 67
[Behavior of plasma pancreatic polypeptides and motilin in obese patientssubjected to biliopancreatic bypass]. 66
COMPOSIZIONE CORPOREA IN PAZIENTI OBESI 65
Diagnostic assessment and outcome of acute pancreatitis in Italy: Results of a prospective multicentre study. ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II 65
cHANGES IN BODY COMPOSITION FOLLWOING BILIOPANCREATIC BYPASS (BPB) 65
BONE HISTOMORPHOMETRY FOLLOWING BILIOPANCREATIC DIVERSION (BPD) 65
PARTIAL AND TOTAL BYPASS IN THE SURGICAL REATMENT OF OBESITY. 65
TIMING OF SURGERY RELATED TO MENSTRUAL CYCLE AND PROGNOSIS OF PREMENOPAUSAL WOMEN WITH BREAST CANCER. 64
Surgical revision of biliopancreatic bypass. 64
[Automated determination of total nitrogen in urine and feces]. 64
SINDROME OCULOCUTANEA DOPO DIVERSIONE BILIOPANCREATICA TOTALE 63
ASSORBIMENTO DELLA VITAMINA B12 DOPO BYPASS BILIOPANCREATICO PER L'OBESITA'. 63
INTESTINAL ADAPTION FOLLOWING BILIOPANCREATIC BYPASS. 63
[Behavior of plasma enteroglucagon and neurotensin in obese patients subjected tobiliopancreatic bypass]. 62
LONG-TERM RESULTS OF BILIOPANCREATIC DIVERSION IN SUBJECTS WITH PRADER-WILLI SYNDROME 62
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 62
AUTOTRASFUSIONE NEL BYPASS BILIOPANCREATICO PER LA TERAPIA CHIRURGICA FUNZIONALE DELL'OBESITA'. RAPPORTO PRELIMINARE. 61
Totale 8.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.869
article - articoli 34.669
book - libri 0
conference - conferenze 176
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.024
Totale 71.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.703 57 54 145 106 231 261 448 121 202 621 350 107
2020/2021943 81 65 121 88 15 107 72 41 132 61 81 79
2021/20222.011 28 166 131 372 86 114 142 424 87 159 59 243
2022/20232.053 221 112 18 189 331 376 26 178 312 16 240 34
2023/20241.000 57 126 15 134 80 202 34 61 44 40 71 136
2024/202580 80 0 0 0 0 0 0 0 0 0 0 0
Totale 11.776